239 related articles for article (PubMed ID: 25843597)
1. Control of immunopathology during chikungunya virus infection.
Petitdemange C; Wauquier N; Vieillard V
J Allergy Clin Immunol; 2015 Apr; 135(4):846-855. PubMed ID: 25843597
[TBL] [Abstract][Full Text] [Related]
2. Cellular and Molecular Immune Response to Chikungunya Virus Infection.
Tanabe ISB; Tanabe ELL; Santos EC; Martins WV; Araújo IMTC; Cavalcante MCA; Lima ARV; Câmara NOS; Anderson L; Yunusov D; Bassi ÊJ
Front Cell Infect Microbiol; 2018; 8():345. PubMed ID: 30364124
[TBL] [Abstract][Full Text] [Related]
3. Control of Acute Arboviral Infection by Natural Killer Cells.
Maucourant C; Petitdemange C; Yssel H; Vieillard V
Viruses; 2019 Jan; 11(2):. PubMed ID: 30709036
[TBL] [Abstract][Full Text] [Related]
4. Chikungunya Virus-Induced Arthritis: Role of Host and Viral Factors in the Pathogenesis.
Amdekar S; Parashar D; Alagarasu K
Viral Immunol; 2017 Dec; 30(10):691-702. PubMed ID: 28910194
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal Antibodies as Prophylactic and Therapeutic Agents Against Chikungunya Virus.
Clayton AM
J Infect Dis; 2016 Dec; 214(suppl 5):S506-S509. PubMed ID: 27920182
[TBL] [Abstract][Full Text] [Related]
6. Chikungunya virus pathogenesis and immunity.
Gasque P; Couderc T; Lecuit M; Roques P; Ng LF
Vector Borne Zoonotic Dis; 2015 Apr; 15(4):241-9. PubMed ID: 25897810
[TBL] [Abstract][Full Text] [Related]
7. Recent development in the strategies projected for chikungunya vaccine in humans.
Goyal M; Chauhan A; Goyal V; Jaiswal N; Singh S; Singh M
Drug Des Devel Ther; 2018; 12():4195-4206. PubMed ID: 30573950
[TBL] [Abstract][Full Text] [Related]
8. Immunopathology of Chikungunya Virus Infection: Lessons Learned from Patients and Animal Models.
Ng LFP
Annu Rev Virol; 2017 Sep; 4(1):413-427. PubMed ID: 28637387
[TBL] [Abstract][Full Text] [Related]
9. A Review on Chikungunya Virus Epidemiology, Pathogenesis and Current Vaccine Development.
de Lima Cavalcanti TYV; Pereira MR; de Paula SO; Franca RFO
Viruses; 2022 May; 14(5):. PubMed ID: 35632709
[TBL] [Abstract][Full Text] [Related]
10. Antibody-based therapeutic interventions: possible strategy to counter chikungunya viral infection.
Kumar R; Shrivastava T; Samal S; Ahmed S; Parray HA
Appl Microbiol Biotechnol; 2020 Apr; 104(8):3209-3228. PubMed ID: 32076776
[TBL] [Abstract][Full Text] [Related]
11. Chikungunya, a paradigm of neglected tropical disease that emerged to be a new health global risk.
Rougeron V; Sam IC; Caron M; Nkoghe D; Leroy E; Roques P
J Clin Virol; 2015 Mar; 64():144-52. PubMed ID: 25453326
[TBL] [Abstract][Full Text] [Related]
12. Development of Vaccines for Chikungunya Fever.
Erasmus JH; Rossi SL; Weaver SC
J Infect Dis; 2016 Dec; 214(suppl 5):S488-S496. PubMed ID: 27920179
[TBL] [Abstract][Full Text] [Related]
13. Disease Resolution in Chikungunya-What Decides the Outcome?
Srivastava P; Kumar A; Hasan A; Mehta D; Kumar R; Sharma C; Sunil S
Front Immunol; 2020; 11():695. PubMed ID: 32411133
[TBL] [Abstract][Full Text] [Related]
14. Cellular and molecular mechanisms of chikungunya pathogenesis.
Lum FM; Ng LF
Antiviral Res; 2015 Aug; 120():165-74. PubMed ID: 26092642
[TBL] [Abstract][Full Text] [Related]
15. A Rodent Model of Chikungunya Virus Infection in RAG1 -/- Mice, with Features of Persistence, for Vaccine Safety Evaluation.
Seymour RL; Adams AP; Leal G; Alcorn MD; Weaver SC
PLoS Negl Trop Dis; 2015; 9(6):e0003800. PubMed ID: 26115459
[TBL] [Abstract][Full Text] [Related]
16. Analysis of Humoral Immune Responses in Chikungunya Virus (CHIKV)-Infected Patients and Individuals Vaccinated With a Candidate CHIKV Vaccine.
Henss L; Yue C; Von Rhein C; Tschismarov R; Lewis-Ximenez LL; Dölle A; Baylis SA; Schnierle BS
J Infect Dis; 2020 Apr; 221(10):1713-1723. PubMed ID: 31828322
[TBL] [Abstract][Full Text] [Related]
17. Immune-Mediated Protection and Pathogenesis of Chikungunya Virus.
Fox JM; Diamond MS
J Immunol; 2016 Dec; 197(11):4210-4218. PubMed ID: 27864552
[TBL] [Abstract][Full Text] [Related]
18. Neutrophil Extracellular Traps Effectively Control Acute Chikungunya Virus Infection.
Hiroki CH; Toller-Kawahisa JE; Fumagalli MJ; Colon DF; Figueiredo LTM; Fonseca BALD; Franca RFO; Cunha FQ
Front Immunol; 2019; 10():3108. PubMed ID: 32082301
[TBL] [Abstract][Full Text] [Related]
19. Optimized production and immunogenicity of an insect virus-based chikungunya virus candidate vaccine in cell culture and animal models.
Adam A; Luo H; Osman SR; Wang B; Roundy CM; Auguste AJ; Plante KS; Peng BH; Thangamani S; Frolova EI; Frolov I; Weaver SC; Wang T
Emerg Microbes Infect; 2021 Dec; 10(1):305-316. PubMed ID: 33539255
[TBL] [Abstract][Full Text] [Related]
20. Molecular epidemiology, evolution and phylogeny of Chikungunya virus: An updating review.
Lo Presti A; Cella E; Angeletti S; Ciccozzi M
Infect Genet Evol; 2016 Jul; 41():270-278. PubMed ID: 27085290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
